These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11294523)

  • 1. Inhibition of thrombin by iopromide in vitro.
    Graf LL; Young DA; Kressin DC; Marlar RA; Jacob GB; Hinderling PH
    Ther Drug Monit; 2001 Apr; 23(2):93-9. PubMed ID: 11294523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
    Druy EM; Bettmann MA; Jeans W
    Invest Radiol; 1994 May; 29 Suppl 1():S102-5; discussion S106. PubMed ID: 8071036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of iopromide with iohexol and iopamidol in coronary arteriography and left ventriculography.
    Bergelson B; Bettmann MA; Wexler L; Wilson R; Dyet J
    Invest Radiol; 1994 May; 29 Suppl 1():S107-11; discussion S118-9. PubMed ID: 8071037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of iopromide in cerebral arteriography.
    Haughton VM; Papke RA; Hyland D; Drayer BP; Osborn AG; Maravilla K; Hilal SK
    Invest Radiol; 1994 May; 29 Suppl 1():S94-7. PubMed ID: 8071052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind study of the safety, tolerance, and diagnostic efficacy of iopromide as compared with iopamidol and iohexol in patients requiring aortography and visceral angiography.
    Faykus MH; Cope C; Athanasoulis C; Druy EM; Hedgcock M; Miller FJ; Bron K
    Invest Radiol; 1994 May; 29 Suppl 1():S98-101; discussion S106. PubMed ID: 8071053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
    Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
    Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions of low osmolar non-ionic and ionic contrast media when used together or separately during percutaneous coronary intervention.
    Juergens CP; Khaing AM; McIntyre GJ; Leung DY; Lo ST; Fernandes C; Hopkins AP
    Heart Lung Circ; 2005 Sep; 14(3):172-7. PubMed ID: 16352273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angiography and stenting.
    Scheller B; Speck U; Schmitt A; Clauss W; Sovak M; Böhm M; Stoll HP
    Invest Radiol; 2002 Jan; 37(1):29-34. PubMed ID: 11753151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative assays of the chemotoxicity of iodinated radiographic contrast media based on impairment of fibrin antithrombin activity.
    Schulze B; Beyer HK
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():21-3. PubMed ID: 2568797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical evidence for a relative lack of inhibition of thrombin formation by nonionic contrast media.
    Mamon JF; Hoppensteadt D; Fareed J; Moncada R
    Radiology; 1991 May; 179(2):399-402. PubMed ID: 2014281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular contrast media and thrombin generation.
    Parvez Z; Vik H
    Acta Radiol; 1994 Mar; 35(2):172-5. PubMed ID: 8172746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
    Lubbers MM; Kock M; Niezen A; Galema T; Kofflard M; Bruning T; Kooij HS; van Valen H; Dijkshoorn M; Booij R; Padmos A; Vogels A; Budde RPJ; Nieman K
    Radiology; 2018 Jan; 286(1):71-80. PubMed ID: 28809582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
    Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac and hemodynamic tolerability of iopromide with or without sodium or iloprost and of ioversol in the anesthetized rat.
    Krause W; Muschick P; Wehrmann D
    Invest Radiol; 1994 Nov; 29(11):978-84. PubMed ID: 7534283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular diastolic impairment during coronary arteriography with a non-ionic contrast medium.
    Baglini R; Sesana M; Capuano C; Rosella MG; Sardeo C; Danzi GB
    Minerva Cardioangiol; 2004 Aug; 52(4):323-8. PubMed ID: 15284681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nonionic radiocontrast medium iopromide does not release endothelin-1 or activate cardiac mast cells during coronary angiography.
    Simon MR; Reher RL; Long PM; Yellayi K
    Int Arch Allergy Immunol; 2003 May; 131(1):53-6. PubMed ID: 12759490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.